Larvol Delta - Longterm-outcomes-of-eltrombopag-plus-cyclosporine-A-in-eltrombopagexposed-patients-with-glucocorticoidresistant-or-dependent-primary-immune-thrombocytopenia-a-prospective-multicenter-singlearm-phase-II-study-with-extended-followup

omipalisib (GSK2126458) - GSK

Mekinist (trametinib) - Novartis, BeOne Medicines

http://clinicaltrials.gov/ct2/show/NCT02015117

Sep 26, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next